Products
Explore our advanced sequencing products for turning complex molecular signals into high-confidence readouts across clinical testing, RNA quality control, and translational methylation programs.


BYU researchers are collaborating with the University of Kansas Alzheimer’s Disease Research Center (KU AADRC) to pave the way for early detection through a validation study of a blood test designed to detect Alzheimer’s disease neurodegeneration in its infancy. If successful, this test could support Alzheimer’s research and earlier detection, monitor disease progression, and lay the foundation for new diagnostic tools and treatments.